Expanded Access to Tenofovir
October 9, 2001
Tenofovir, also known as Viread, is a type of anti-HIV drug called a nucleotide reverse transcriptase inhibitor. Tenofovir is not a major breakthough -- it is not as potent as, say, the protease inhibitor indinavir (Crixivan). However, the advantage with tenofovir is that it only has to be taken once a day. Tenofovir will likely be approved for use only in people who have previously used anti-HIV medications. Until then, the manufacturer, Gilead Sciences, is making tenofovir available at no cost for physicians to give to some people with HIV/AIDS in the following countries:
Gilead will consider requests for tenofovir from physicians in Canada for their patients with the following profile:
For more information about the tenofovir expanded access program or to register patients in Canada and the U.S., physicians can phone: 1.877.226.8802. Physicians in Europe can call this number: 126.96.36.199.34.46.
Registration materials can be requested online by visiting the Gilead website at: http://www.gilead.com/webpage_templates/frame_home.php3.
A CATIE fact sheet about tenofovir is under development and will be available shortly.
This article was provided by Canadian AIDS Treatment Information Exchange. Visit CATIE's Web site to find out more about their activities, publications and services.